Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
215 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
33 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
47 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬